China Biologic Products Schedules 2009 Second Quarter Earnings Conference Call
August 13 2009 - 9:30AM
PR Newswire (US)
TAIAN CITY, China, Aug. 13 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (OTC:CBPO) (BULLETIN BOARD: CBPO) ("China
Biologic" or the "Company"), one of the leading plasma-based
pharmaceutical companies in the People's Republic of China ("PRC"),
today announced that it will host a conference call at 9:00 a.m.
EDT on Monday, August 17, 2009, to discuss the 2009 second quarter
financial results. Hosting the call will be Mr. Colin Zhao, Chief
Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. To
participate in the live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call
time: 866- 800-8648. International callers should dial
+1-617-614-2702. The pass code for the call is 874 753 42. If you
are unable to participate in the call at this time, a replay will
be available for 14 days starting on Monday, August 17, 2009 at
11:00 a.m. EDT. To access the replay, dial 888-286-8010,
international callers should dial 617-801-6888. The conference pass
code is 406 925 80. About China Biologic Products, Inc. China
Biologic Products, Inc. (the "Company"), through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co. Ltd. and Chongqing Dalin Biologic Technologies Co., Ltd, and
its equity investment in Xi'an Huitian Blood Products Co., Ltd., is
currently the largest non-state- owned plasma-based
biopharmaceutical company approved by the Chinese government. The
Company is a fully integrated biologic products company with plasma
collection, production and manufacturing, research and development,
and commercial operations. The Company's blood products are
irreplaceable during medical emergencies, and are used for the
prevention and treatment of various diseases. It sells its
plasma-based biopharmaceutical products to hospitals and other
healthcare facilities in China. For more information, please
contact: Company Contact: Mr. Y. Tristan Kuo Chief Financial
Officer China Biologic Products, Inc. Tel: +86-538-6202206 Email:
Web: http://www.chinabiologic.com/ Investor Relations Contact: Mr.
Crocker Coulson, President CCG Investor Relations Tel:
+1-646-213-1915 (NY office) or Mr. Gary Chin Tel: +1-646-213-1909
Email: Web: http://www.ccgirasia.com/ DATASOURCE: China Biologic
Products, Inc. CONTACT: Mr. Y. Tristan Kuo, Chief Financial Officer
of China Biologic Products, Inc., +86-538-6202206, ; or Crocker
Coulson, President, +1-646-213-1915, , or Gary Chin,
+1-646-213-1909, both of CCG Investor Relations Web site:
http://www.chinabiologic.com/
Copyright